Analysts Offer Insights on Healthcare Companies: Cigna (CI), Thermo Fisher (TMO) and McKesson (MCK)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Cigna (CI – Research Report), Thermo Fisher (TMO – Research Report) and McKesson (MCK – Research Report) with bullish sentiments.

Cigna (CI)

In a report released today, Erin Wright from Morgan Stanley maintained a Buy rating on Cigna, with a price target of $365.00. The company’s shares closed last Friday at $302.46.

According to TipRanks.com, Wright is a 5-star analyst with an average return of 16.1% and a 64.7% success rate. Wright covers the Healthcare sector, focusing on stocks such as Phibro Animal Health, Idexx Laboratories, and DENTSPLY SIRONA.

Cigna has an analyst consensus of Moderate Buy, with a price target consensus of $359.57.

See Insiders’ Hot Stocks on TipRanks >>

Thermo Fisher (TMO)

SVB Securities analyst Puneet Souda maintained a Buy rating on Thermo Fisher today and set a price target of $620.00. The company’s shares closed last Friday at $534.07.

According to TipRanks.com, Souda ‘s ranking currently consits of 0 on a 0-5 ranking scale, with an average return of -11.8% and a 37.8% success rate. Souda covers the Healthcare sector, focusing on stocks such as AbCellera Biologics, Castle Biosciences, and Twist Bioscience.

Thermo Fisher has an analyst consensus of Strong Buy, with a price target consensus of $614.91.

McKesson (MCK)

Morgan Stanley analyst Ricky Goldwasser maintained a Buy rating on McKesson today and set a price target of $420.00. The company’s shares closed last Friday at $384.54, close to its 52-week high of $401.78.

According to TipRanks.com, Goldwasser is a 5-star analyst with an average return of 13.1% and a 64.3% success rate. Goldwasser covers the Healthcare sector, focusing on stocks such as Lifestance Health Group, Quest Diagnostics, and Elevance Health.

McKesson has an analyst consensus of Strong Buy, with a price target consensus of $425.83, a 12.7% upside from current levels. In a report issued on January 4, Bank of America Securities also maintained a Buy rating on the stock with a $437.00 price target.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Read More on CI:

• Wells Fargo downgrades Cigna to Equal Weight, lowers price target to $355
• Cigna downgraded to Equal Weight from Overweight at Wells Fargo
• Walmart to pay $500,000 over workers’ compensation prescription procedures
• Managed care company returns will be tough to keep replicating, WSJ says
• WBA to invest $3.5B to support VillageMD acquisition of Summit Healt-CityMD